SynthesisFrontiers in neurology2026
Association between neutrophil-to-lymphocyte ratio and cerebral small vessel disease: a systematic review and meta-analysis.
Synthesis in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives: Cerebral small vessel disease (CSVD) causes about 25% of ischemic strokes, most intracerebral hemorrhages, and is a major cause of vascular dementia. The neutrophil-to-lymphocyte ratio (NLR), an inflammatory marker, has shown inconsistent associations with CSVD. We performed a meta-analysis to quantify the association between NLR and CSVD imaging markers. Methods: Pubmed, Embase, and Cochrane Library were searched through August 10, 2025 for studies of NLR and CSVD. Fifteen studies ( Results: Elevated NLR was associated with presence of CSVD (OR 1.43, 95% CI 1.07-1.93) and greater total CSVD burden (OR 1.55, 95% CI 1.11-2.18). NLR also had associations with WMH (severe WMH: OR 1.36, 95% CI 1.04-1.76; WMH volume: β=0.08, 95% CI 0.02-0.15) and lacunes (OR 1.26, 95% CI 1.16-1.36); it was not associated with CMBs (OR 0.94, 95% CI 0.82-1.09), and EPVS data were limited. Substantial heterogeneity was noted for CSVD and WMH but not for lacunes or CMBs. Removing one study resolved heterogeneity for total CSVD burden, and excluding a high-bias study eliminated the WMH severity association. Conclusion: Higher NLR showed a limited but consistent association with ischemic CSVD markers, particularly WMH and lacunes, whereas no association was observed with hemorrhagic markers such as CMBs. NLR may therefore reflect inflammatory pathways more closely related to ischemic small vessel injury, but larger longitudinal studies are needed to confirm its causal and clinical relevance. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251125195, identifier: CRD420251125195.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.